Skip to main content
. 2019 Apr 30;32(9):doz029. doi: 10.1093/dote/doz029

Table 2.

Post-procedure questionnaire and results

Question % Responding ‘Yes’
1 Suspicious areas/disease identified on VLE by the physician? 77% (689/894)
2 Did you see any suspicious areas on VLE that you did NOT see on WLE? 59% (526/894)
3 Did you see any suspicious areas on VLE that you did NOT see using advanced imaging (i.e. NBI, FICE, i-Scan, chromatography, or CLE)? 56% (401/710)
4 Did VLE guide tissue acquisition? 72% (515/714)
5 Did findings on VLE guide treatment at the current visit? 52% (182/352)
6 Was either the depth or extent of disease identified on VLE used to determine treatment modality? 40% (140/353)

CLE, confocal laser endomicroscopy; NBI, narrow band imaging; VLE, volumetric laser endomicroscopy; WLE, white light endoscopy.